Ruzzo Ruzzo A A Graziano Graziano F F Galli Galli F F Galli Galli F F Rulli Rulli E E Lonardi Lonardi S S Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients Br J Cancer Br J Cancer 2017 2017 117 117 1269 1269 77 77 10.1038/bjc.2017.289 10.1038/bjc.2017.289 29065426 29065426. Here, DPYD is linked to malignant colon neoplasm.